Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Blood glucose testing– Market size and forecast 2017-2022
• Cardiometabolic testing – Market size and forecast 2017-2022
• Infectious disease testing – Market size and forecast 2017-2022
• Pregnancy and fertility testing – Market size and forecast 2017-2022
• Fecal occult testing – Market size and forecast 2017-2022
• Toxicology testing – Market size and forecast 2017-2022
• Coagulation testing – Market size and forecast 2017-2022
• Market opportunity by application

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Hospitals and clinics
• Clinical diagnostic laboratories
• Home care settings

PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Rapid diagnostics market in Americas
• Rapid diagnostics market in EMEA
• Rapid diagnostics market in APAC
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 13: MARKET TRENDS
• Growing presence of OEMs
• Use of digital health in rapid diagnostics for POC
• Increasing number of M&A

PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive landscape

PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• BD
• bioMérieux
• Danaher
• F. Hoffmann-La Roche
• Siemens Healthcare
• Other prominent vendors

PART 16: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Global IVD market
Exhibit 02: Global IVD market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Global rapid diagnostics market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global rapid diagnostics market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global rapid diagnostics market – Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Application – Market share 2017-2022 (%)
Exhibit 19: Comparison by application
Exhibit 20: Blood glucose testing by rapid diagnostics– Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Blood glucose testing by rapid diagnostics – Year over year growth 2018-2022 (%)
Exhibit 22: Cardiometabolic testing by rapid diagnostics – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Cardiometabolic testing by rapid diagnostics – Year over year growth 2018-2022 (%)
Exhibit 24: Infectious disease testing by rapid diagnostics – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Infectious disease testing by rapid diagnostics – Year over year growth 2018-2022 (%)
Exhibit 26: Pregnancy and fertility testing by rapid diagnostics – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Pregnancy and fertility testing by rapid diagnostics – Year over year growth 2018-2022 (%)
Exhibit 28: Fecal occult testing by rapid diagnostics– Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Fecal occult testing by rapid diagnostics – Year over year growth 2018-2022 (%)
Exhibit 30: Toxicology testing by rapid diagnostics – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Toxicology testing by rapid diagnostics – Year over year growth 2018-2022 (%)
Exhibit 32: Coagulation testing by rapid diagnostics– Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Toxicology testing by rapid diagnostics – Year over year growth 2018-2022 (%)
Exhibit 34: Market opportunity by application
Exhibit 35: Customer landscape
Exhibit 36: Global rapid diagnostics market by end-user – Market share 2017 (%)
Exhibit 37: Global rapid diagnostics market – Market share by geography 2017-2022 (%)
Exhibit 38: Regional comparison
Exhibit 39: Rapid diagnostics market in the Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 40: Rapid diagnostics market in the Americas – Year over year growth 2018-2022 (%)
Exhibit 41: Top 3 countries in Americas
Exhibit 42: Rapid diagnostics market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 43: Rapid diagnostics market in EMEA – Year over year growth 2018-2022 (%)
Exhibit 44: Top 3 countries in EMEA
Exhibit 45: Rapid diagnostics market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 46: Rapid diagnostics market in APAC – Year over year growth 2018-2022 (%)
Exhibit 47: Top 3 countries in APAC
Exhibit 48: Market opportunity
Exhibit 49: Market impact analysis of M&A
Exhibit 50: Vendor landscape
Exhibit 51: Landscape disruption
Exhibit 52: Vendors covered
Exhibit 53: Vendor classification
Exhibit 54: Market positioning of vendors
Exhibit 55: Abbott overview
Exhibit 56: Abbott: Business segments
Exhibit 57: Abbott: Organizational developments
Exhibit 58: Abbott: Geographic focus
Exhibit 59: Abbott: Segment focus
Exhibit 60: Abbott: Key offerings
Exhibit 61: Abbott: Key customers
Exhibit 62: BD overview
Exhibit 63: BD – Business segments
Exhibit 64: BD – Organizational developments
Exhibit 65: BD – Geographic focus
Exhibit 66: BD – Segment focus
Exhibit 67: BD – Key offerings
Exhibit 68: BD – Key customers
Exhibit 69: bioMérieux: Overview
Exhibit 70: bioMérieux: Business segments
Exhibit 71: bioMérieux: Organizational developments
Exhibit 72: bioMérieux: Geographic focus
Exhibit 73: bioMérieux: Segment focus
Exhibit 74: bioMérieux: Key offerings
Exhibit 75: bioMérieux: Key customers
Exhibit 76: Danaher: Overview
Exhibit 77: Danaher: Business segments
Exhibit 78: Danaher: Organizational developments
Exhibit 79: Danaher: Geographic focus
Exhibit 80: Danaher: Segment focus
Exhibit 81: Danaher: Key offerings
Exhibit 82: Danaher: Key customers
Exhibit 83: F. Hoffmann-La Roche overview
Exhibit 84: F. Hoffmann-La Roche: Business segments
Exhibit 85: F. Hoffmann-La Roche: Organizational developments
Exhibit 86: F. Hoffmann-La Roche: Geographic focus
Exhibit 87: F. Hoffmann-La Roche: Segment focus
Exhibit 88: F. Hoffmann-La Roche: Key offerings
Exhibit 89: F. Hoffmann-La Roche: Key customers
Exhibit 90: Siemens Healthcare: Overview
Exhibit 91: Siemens Healthcare: Business segments
Exhibit 92: Siemens Healthcare: Organizational developments
Exhibit 93: Siemens Healthcare: Geographic focus
Exhibit 94: Siemens Healthcare: Segment focus
Exhibit 95: Siemens Healthcare: Key offerings
Exhibit 96: Siemens Healthcare: Key customers